News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) and Itamar Medical Inc. Move Forward in Developing EndoPATâ„¢ for Pre-Clinical Longitudinal Studies


1/4/2012 6:22:14 AM

CAESAREA, Israel--(BUSINESS WIRE)--Itamar-Medical (TASE: ITMR), the world's leader of non-invasive devices for diagnosis of cardiovascular health, announced achievement of the next milestone of the international pharmaceutical company, Roche, to further develop the EndoPAT technology for pre-clinical trials. This is a continuation of the original announcement from December 2010.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES